Literature DB >> 17525664

Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.

Wuqaas M Munir1, Steven I Rosenfeld, Ira Udell, Darlene Miller, Carol L Karp, Eduardo C Alfonso.   

Abstract

PURPOSE: To report 5 cases of fungal keratitis associated with contact lens wear that resolved or significantly improved without antifungal therapy.
METHODS: Observational case report of 5 patients with a history of contact lens wear who presented with infectious keratitis. Two patients had growth of fungal species on corneal microbiologic cultures, and of the remaining 3 patients, 2 showed fungal elements on confocal microscopy. All 5 patients exhibited growth of fungal species on contact lens microbiologic cultures. All patients received topical fluoroquinolone therapy as initial treatment.
RESULTS: In 3 cases, of whom 2 were treated with moxifloxacin 0.5%, the keratomycosis resolved completely on topical fluoroquinolone therapy. One case was switched to topical tobramycin 14 mg/mL and cefazolin 50 mg/mL with complete resolution of the infection. The final case showed marked initial improvement on fluoroquinolone therapy but was subsequently treated with natamycin 5%.
CONCLUSIONS: Fungal keratitis associated with soft contact lens wear may occasionally present in a less aggressive form. Topical fluoroquinolone therapy may be an adjunct to the innate immune response in eradicating less fulminant keratomycosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525664     DOI: 10.1097/ICO.0b013e318033e7e1

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Fungal keratitis responsive to moxifloxacin monotherapy.

Authors:  Alice Y Matoba
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  [A 25-year-old patient with corneal infiltration].

Authors:  K Aperlic; H-J Tietz; M Erhard; T Regnath
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

3.  Activity of antibiotics against Fusarium and Aspergillus.

Authors:  S Day; P Lalitha; S Haug; A W Fothergill; V Cevallos; R Vijayakumar; N V Prajna; N R Acharya; S D McLeod; T M Lietman
Journal:  Br J Ophthalmol       Date:  2008-10-24       Impact factor: 4.638

4.  Comparison of contamination rates between preserved and preservative-free fluoroquinolone eyedrops.

Authors:  Mo Sae Kim; Hong Kyun Kim; Joon Mo Kim; Chul Young Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-12       Impact factor: 3.117

5.  Early keratectomy in the treatment of moderate Fusarium keratitis.

Authors:  Hsin-Chiung Lin; Ja-Liang Lin; Dan-Tzu Lin-Tan; Hui-Kang Ma; Hung-Chi Chen
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

6.  Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.

Authors:  Darlene Miller
Journal:  Clin Ophthalmol       Date:  2008-03

7.  Fungal keratitis due to Scopulariopsis brevicaulis and a potential promising therapeutic effect of antibacterial agents: A case report.

Authors:  Nasser M Kaplan; Rami A Al-Dwairi; Nasr N AlRabadi
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.